29489-04-1 Usage
General Description
4-Bromo-1-(toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one is a chemical compound with the molecular formula C16H17BrNO3S. It is a derivative of benzazepine and toluene-sulfonamide, and it is used in pharmaceutical research. 4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE has a bromo substituent at the 4-position of the benzene ring and a toluene-sulfonyl group attached to the nitrogen atom, making it a versatile building block for the synthesis of various biologically active molecules. Its potential applications include its use as an intermediate in the production of drugs or as a reagent in organic synthesis. Additionally, it may also have biological activities that are yet to be fully explored.
Check Digit Verification of cas no
The CAS Registry Mumber 29489-04-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,4,8 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 29489-04:
(7*2)+(6*9)+(5*4)+(4*8)+(3*9)+(2*0)+(1*4)=151
151 % 10 = 1
So 29489-04-1 is a valid CAS Registry Number.
InChI:InChI=1/C17H16BrNO3S/c1-12-6-8-13(9-7-12)23(21,22)19-11-10-15(18)17(20)14-4-2-3-5-16(14)19/h2-9,15H,10-11H2,1H3
29489-04-1Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
-
Page/Page column 159-160, (2017/08/07)
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: Formula (I) which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions
A scalable process for the synthesis of 2-methyl-1,4,5,6- tetrahydroimidazo[4,5-d][1]benzazepine monohydrate and 4-[(biphenyl-2- ylcarbonyl)amino]benzoic acid: Two new key intermediates for the synthesis of the AVP antagonist conivaptan hydrochloride
Tsunoda, Takashi,Yamazaki, Atsuki,Mase, Toshiyasu,Sakamoto, Shuichi
, p. 593 - 598 (2012/12/25)
A process for the multikilogram synthesis of the dual vasopressin-receptor antagonist, conivaptan hydrochloride, has been developed. This method relies on the introduction of operationally simple chemistry during the final stages of the process when two k